Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Regional Boards Would Replace IRBs Under NIH Bioethics Proposal

This article was originally published in The Gray Sheet

Executive Summary

A proposal to dramatically restructure the nation's current human research subjects protection system by extending federal regulations to all human research and replacing local institutional review boards with regional ethics boards (REBs) is being circulated at NIH by the Department of Clinical Bioethics

You may also be interested in...

Human Research Protection Alternative Models Discussed By OHRP’s Koski

A human subjects protection strategy in which a central review panel works with a set of local review boards to improve safety for research participants is among several alternative models worth exploring, HHS Office of Human Research Protections Director Greg Koski, MD/PhD, told an Institute of Medicine Clinical Research Roundtable workshop Nov. 5

Regulatory Blessings Helping China CAR-Ts March Closer To Global Cancer Patients?

A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts